Multiple-dose pharmacodynamics and pharmacokinetics of anacetrapib, a potent cholesteryl ester transfer protein (CETP) inhibitor, in healthy subjects

Clin Pharmacol Ther. 2008 Dec;84(6):679-83. doi: 10.1038/clpt.2008.109. Epub 2008 Jun 25.
No abstract available

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • Adolescent
  • Adult
  • Cholesterol Ester Transfer Proteins / administration & dosage
  • Cholesterol Ester Transfer Proteins / antagonists & inhibitors*
  • Dose-Response Relationship, Drug
  • Double-Blind Method
  • Drug Administration Schedule
  • Humans
  • Male
  • Middle Aged
  • Oxazolidinones / administration & dosage
  • Oxazolidinones / pharmacokinetics*
  • Oxazolidinones / pharmacology*
  • Reference Values
  • Risk Factors
  • Sensitivity and Specificity
  • Young Adult

Substances

  • Cholesterol Ester Transfer Proteins
  • Oxazolidinones
  • anacetrapib